Inebilizumab, a first-in-class CD19+ B-cell–targeting agent, is safe and effective for up to 1 year in patients with ...

Administrative layoffs at Connecticut's largest private employer signal stresses on academic medical centers facing federal ...

The American Association for the Advancement of Science recognized Yale researchers for their contributions to medicine, ...

The randomized control period of the MINT trial has completed, and these newest data describe outcomes among patients who ...

Allison Aviles, of New Britain, has suffered back-to-back ankle injuries. Last fall, she had surgery after tearing a tendon ...

Craig Roy is the Waldemar Von Zedtwitz Professor of Microbial Pathogenesis and of Immunobiology at Yale School of Medicine (YSM) and director of the Yale Combined Program in the Biological and ...

Richard Lifton, president of The Rockefeller University and an eminent life scientist and educator, will join the Corporation as of July 1, 2025.

Scientists have re-created a pain pathway in the brain by growing four key clusters of human nerve cells in a dish. This ...

Attention-deficit/hyperactivity disorder was once thought to be a condition that only affects children, but awareness has grown that it often persists into adulthood. A recent webinar explored how ...

the Dorys McConnell Duberg Professor of Neuroscience and Cell Biology at Yale School of Medicine and co-chair of the inauguration planning committee. “We are an institution that was designed and ...

In today’s Health headlines, we’re talking with an infectious diseases doctor for an update on the measles outbreak, what to know about the hantavirus during spring ...

In today’s health headlines, invasive strep infections are on the rise. New research proposes a possible cause of food ...